Nitric oxide-eluting nanocomposite for cardiovascular implants

Journal of Materials Science: Materials in Medicine

Volumn 25, Issue 3, 2014, Pages 917-929

  De Mel, Achala ^a   Naghavi, Noora ^a   Cousins, Brian G ^a   Clatworthy, Innes ^c   Hamilton, George ^b   Darbyshire, Arnold ^a   Seifalian, Alexander M ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

^c ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESION; CARDIOVASCULAR SYSTEM; METABOLISM; PLATELETS; PULSATILE FLOW; SCANNING ELECTRON MICROSCOPY; UREA;

CARDIOVASCULAR IMPLANTS; CORONARY ARTERY BYPASS GRAFT; ENDOTHELIAL PROGENITOR CELLS (EPCS); IN-SITU MEASUREMENT; INTIMAL HYPERPLASIA; PHYSIOLOGICAL PULSATILE FLOWS; S-NITROSOGLUTATHIONE; SMOOTH MUSCLE CELLS;

NITRIC OXIDE;

N ACETYL S NITROSOPENICILLAMINE; NANOCOMPOSITE; NITRIC OXIDE; NITRIC OXIDE DONOR; OLIGOMER; POLYCARBONATE; POLYHEDRAL OLIGOMERIC SILSESQUIOXANE POLY(CARBONATE UREA) URETHANE; POLYMER; POLYURETHAN; S NITROSOGLUTATHIONE; UNCLASSIFIED DRUG;

AMPEROMETRY; ARTERY INTIMA PROLIFERATION; ARTICLE; CARDIAC IMPLANT; CELL ADHESION; COMPOSITE GRAFT; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG MECHANISM; DRUG RELEASE; ENDOTHELIAL PROGENITOR CELL; GRAFT PATENCY; HEMODYNAMICS; HUMAN; HUMAN CELL; N ACETYL S NITROSOPENICILLAMINE POLYHEDRAL OLIGOMERIC SILSESQUIOXANE POLY(CARBONATE UREA) URETHANE NANOCOMPOSITE GRAFT; NITRIC OXIDE ELUTING NANOCOMPOSITE GRAFT; PRIORITY JOURNAL; PULSATILE FLOW; RESAZURIN ASSAY; S NITROSOGLUTATHIONE POLYHEDRAL OLIGOMERIC SILSESQUIOXANE POLY(CARBONATE UREA) URETHANE NANOCOMPOSITE GRAFT; SCANNING ELECTRON MICROSCOPY; THROMBOCYTE ADHESION; THROMBOELASTOGRAPHY; THROMBOGENICITY; THROMBOSIS;

ADSORPTION; BLOOD VESSEL PROSTHESIS; CARDIOTONIC AGENTS; DRUG-ELUTING STENTS; ENDOTHELIAL CELLS; EQUIPMENT FAILURE ANALYSIS; HUMANS; MATERIALS TESTING; NANOCAPSULES; NANOCOMPOSITES; NITRIC OXIDE; PARTICLE SIZE; PROSTHESIS DESIGN;

EID: 84896547600     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-013-5103-2     Document Type: Article

References (46)

1. Tousoulis D, Kampoli AM, Tentolouris C, Papageorgiou N, Stefanadis C. The role of nitric oxide on endothelial function. Curr Vasc Pharmacol. 2012;10(1):4-18.
2. de Mel A, Murad F, Seifalian AM. Nitric oxide: a guardian for vascular grafts? Chem Rev. 2011;111(9):5742-67.
3. Naghavi N, de Mel A, Alavijeh OS, Cousins BG, Seifalian AM. Nitric oxide donors for cardiovascular implant applications. Small. 2013;9(1):22-35.
4. Heikal L, Aaronson PI, Ferro A, Nandi M, Martin GP, Dailey LA. S-nitrosophytochelatins: investigation of the bioactivity of an oligopeptide nitric oxide delivery system. Biomacromolecules. 2011;12(6):2103-13.
5. Stasko NA, Fischer TH, Schoenfisch MH. S-nitrosothiol-modified dendrimers as nitric oxide delivery vehicles. Biomacromolecules. 2008;9(3):834-41.
6. Coneski PN, Rao KS, Schoenfisch MH. Degradable nitric oxide-releasing biomaterials via post-polymerization functionalization of cross-linked polyesters. Biomacromolecules. 2010;11:3208-15.
7. de Mel A, Jell G, Stevens MM, Seifalian AM. Biofunctionalization of biomaterials for accelerated in situ endothelialization: a review. Biomacromolecules. 2008;9(11):2969-79.
8. de Mel A, Punshon G, Ramesh B, Sarkar S, Darbyshire A, Hamilton G, et al. In situ endothelialization potential of a biofunctionalised nanocomposite biomaterial-based small diameter bypass graft. Biomed Mater Eng. 2009;19(4-5):317-31.
9. Zhang Y, Hogg N. S-Nitrosothiols: cellular formation and transport. Free Radic Biol Med. 2005;38(7):831-8.
10. Major TC, Brant DO, Burney CP, Amoako KA, Annich GM, Meyerhoff ME, et al. The hemocompatibility of a nitric oxide generating polymer that catalyzes S-nitrosothiol decomposition in an extracorporeal circulation model. Biomaterials. 2011;32(26):5957-69.
11. Dicks AP, Williams DL. Generation of nitric oxide from S-nitrosothiols using protein-bound Cu2 + sources. Chem Biol. 1996;3(8):655-9.
12. Burg A, Cohen H, Meyerstein D. The reaction mechanism of nitrosothiols with copper(I). J Biol Inorg Chem. 2000;5(2):213-7.
13. Kashiba-Iwatsuki M, Kitoh K, Kasahara E, Yu H, Nisikawa M, Matsuo M, et al. Ascorbic acid and reducing agents regulate the fates and functions of S-nitrosothiols. J Biochem. 1997;122(6):1208-14.
14. Melzer MM, Li E, Warren TH. Reversible RS-NO bond cleavage and formation at copper(I) thiolates. Chem Commun (Camb). 2009;39:5847-9.
15. Singh RJ, Hogg N, Joseph J, Kalyanaraman B. Mechanism of nitric oxide release from S-nitrosothiols. J Biol Chem. 1996;271(31):18596-603.
16. Salacinski HJ, Handcock S, Seifalian AM, inventors; polymer for use in conduits and medical devices. Patent No.: WO2005070998. 2005.
17. Kannan RY, Salacinski HJ, De GJ, Clatworthy I, Bozec L, Horton M, et al. The antithrombogenic potential of a polyhedral oligomeric silsesquioxane (POSS) nanocomposite. Biomacromolecules. 2006;7(1):215-23.
18. Ahmed M, Ghanbari H, Cousins BG, Hamilton G, Seifalian AM. Small calibre polyhedral oligomeric silsesquioxane nanocomposite cardiovascular grafts: influence of porosity on the structure, haemocompatibility and mechanical properties. Acta Biomater. 2011;7(11):3857-67.
19. Chaloupka K, Motwani M, Seifalian AM. Development of a new lacrimal drainage conduit using POSS nanocomposite. Biotechnol Appl Biochem. 2011;58(5):363-70.
20. Jungebluth P, Alici E, Baiguera S, Le BK, Blomberg P, Bozoky B, et al. Tracheobronchial transplantation with a stem-cell-seeded bioartificial nanocomposite: a proof-of-concept study. Lancet. 2011;378(9808):1997-2004.
21. Sarkar S, Burriesci G, Wojcik A, Aresti N, Hamilton G, Seifalian AM. Manufacture of small calibre quadruple lamina vascular bypass grafts using a novel automated extrusion-phase-inversion method and nanocomposite polymer. J Biomech. 2009;42(6):722-30.
22. Ahmed M, Ghanbari H, Cousins BG, Hamilton G, Seifalian AM. Small calibre polyhedral oligomeric silsesquioxane nanocomposite cardiovascular grafts: influence of porosity on the structure, haemocompatibility and mechanical properties. Acta Biomater. 2011;7(11):3857-67.
23. Verma S, Marsden PA. Nitric oxide-eluting polyurethanes-vascular grafts of the future? N Engl J Med. 2005;353(7):730-1.
24. Sarkar S, Burriesci G, Wojcik A, Aresti N, Hamilton G, Seifalian AM. Manufacture of small calibre quadruple lamina vascular bypass grafts using a novel automated extrusion-phase-inversion method and nanocomposite polymer. J Biomech. 2009;42(6):722-30.
25. Davies IR, Zhang X. 2008. Nitric oxide selective electrodes. methods in enzymology. p. 1-29.
26. Wadsworth R, Stankevicius E, Simonsen U. Physiologically relevant measurements of nitric oxide in cardiovascular research using electrochemical microsensors. J Vasc Res. 2006;43(1):70-85.
27. Apollo 1000. http://www.wpiinc.com/pdf/Apollo1000-IMpdf. 2012.
28. Punshon G, Sales KM, Vara DS, Hamilton G, Seifalian AM. Assessment of the potential of progenitor stem cells extracted from human peripheral blood for seeding a novel vascular graft material. Cell Prolif. 2008;41(2):321-35.
29. Seifalian AM, Salacinski HJ, Punshon G, Krijgsman B, Hamilton G. A new technique for measuring the cell growth and metabolism of endothelial cells seeded on vascular prostheses. J Biomed Mater Res. 2001;55(4):637-44.
30. Vaughn MW, Kuo L, Liao JC. Estimation of nitric oxide production and reaction rates in tissue using a mathematical model. Am J Physiol. 2000;274:H2163-76.
31. Bramanti E, Angeli V, Paolicchi A, Pompella A. The determination of S-nitrosothiols in biological samples-procedures, problems and precautions. Life Sci. 2011;88(3-4):126-9.
32. Zhang X. Real time and in vivo monitoring of nitric oxide by electrochemical sensors-from dream to reality. Front Biosci. 2004;9:3434-46.
33. Park SS, Hong M, Song CK, Jhon GJ, Lee Y, Suh M. Real-time in vivo simultaneous measurements of nitric oxide and oxygen using an amperometric dual microsensor. Anal Chem. 2010;82(18):7618-24.
34. Nitric oxide probe WPI. http://www.wpiinc.com/indexphp/vmchk/ISO-NOP html 2012.
35. Noh H, Vogler EA. Volumetric interpretation of protein adsorption: competition from mixtures and the Vroman effect. Biomaterials. 2007;28(3):405-22.
36. Kots AY, Bian K, Murad F. Nitric oxide and cyclic GMP signaling pathway as a focus for drug development. Curr Med Chem. 2011;18(22):3299-305.
37. de Mel A, Murad F, Seifalian AM. Nitric oxide: a guardian for vascular grafts? Chem Rev. 2011;111(9):5742-67.
38. Huang J, Lin SC, Nadershahi A, Watts SW, Sarkar R. Role of redox signaling and poly (adenosine diphosphate-ribose) polymerase activation in vascular smooth muscle cell growth inhibition by nitric oxide and peroxynitrite. J Vasc Surg. 2008;47(3):599-607.
39. Kannan RY, Salacinski HJ, De GJ, Clatworthy I, Bozec L, Horton M, et al. The antithrombogenic potential of a polyhedral oligomeric silsesquioxane (POSS) nanocomposite. Biomacromolecules. 2006;7(1):215-23.
40. de Mel A, Murad F, Seifalian AM. Nitric oxide: a guardian for vascular grafts? Chem Rev. 2011;111(9):5742-67.
41. Saraiva J, Marotta-Oliveira SS, Cicillini SA, Eloy JO, Marchetti JM. Nanocarriers for nitric oxide delivery. J Drug Deliv. 2011;2011:936438.
42. Eroy-Reveles AA, Mascharak PK. Nitric oxide-donating materials and their potential in pharmacological applications for site-specific nitric oxide delivery. Future Med Chem. 2009;1(8):1497-507.
43. Sortino S. Light-controlled nitric oxide delivering molecular assemblies. Chem Soc Rev. 2010;39(8):2903-13.
44. Yoo JW, Choe ES, Ahn SM, Lee CH. Pharmacological activity and protein phosphorylation caused by nitric oxide-releasing microparticles. Biomaterials. 2010;31(3):552-8.
45. Donadee C, Raat NJ, Kanias T, Tejero J, Lee JS, Kelley EE, et al. Nitric oxide scavenging by red blood cell microparticles and cell-free hemoglobin as a mechanism for the red cell storage lesion. Circulation. 2011;124(4):465-76.
46. Zhang X, Cardosa L, Broderick M, Fein H, Davies I. Novel Calibration Method for Nitric Oxide Microsensors by Stoichiometrical Generation of Nitric Oxide from SNAP. Electroanalysis. 2000;12(6):425-8.